Factors affecting posttransfusion platelet efficiency "close relationship between patient and product";Facteurs influençant le rendement transfusionnel plaquettaire « une interdépendance entre le patient et le produit »

Transfusion Clinique et Biologique

Volumn 14, Issue 1, 2007, Pages 90-93

  Sensebé, Luc ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Platelet doses; Platelet transfusion; Platelet transfusion efficiency; Refractoriness; Storage duration

Indexed keywords

AMPHOTERICIN; THROMBOCYTE FACTOR;

BLOOD GROUP ABO INCOMPATIBILITY; DISSEMINATED INTRAVASCULAR CLOTTING; FEVER; HLA SYSTEM; HUMAN; INFECTION; SHORT SURVEY; SPLENOMEGALY; THROMBOCYTE TRANSFUSION;

ABO BLOOD-GROUP SYSTEM; BLOOD PLATELETS; HLA ANTIGENS; HUMANS; PLATELET TRANSFUSION; TREATMENT OUTCOME;

EID: 34249943968     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2007.03.007     Document Type: Short Survey

References (13)

1. Davis K.B., Slichter S.J., and Corash L. Corrected count increment and percent platelet recoveryas measures of post-transfusion platelet response: problems and a solution. Transfusion 39 (1999) 586-592
2. Slichter S., Davis K., Enright H., Braine H., Gernsheimer T., Kao K.-J., et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 105 (2005) 4106-4114
3. Hanson S.R., and Slichter S. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 66 (1985) 1105-1109
4. Rebulla P., Finazzi G., Marangoni F., et al. The threshold for prophylactic platelet transfusions in adults with acute myelogenous leukemia. N Engl J Med 337 (1997) 1870-1875
5. -1 trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 91 (1998) 3601-3606
6. Norol F., Bierling P., Roudot-Thoraval F., Le Cœur F.F., Rieux C., Lavaux A., et al. Platelet transfusion: a dose-response study. Blood 92 (1998) 1448-1453
7. Sensebé L., Giraudeau B., Bardiaux L., Deconinck E., Schmidt A., Bidet M.L., et al. The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study. Blood 105 (2005) 862-864
8. Ackerman S.J., Klumpp T.R., Guzman G.I., Herman J.H., Gaughan J.P., Bleeker G.C., et al. Economic consequences of alterations in platelet transfusion dose: analysis of a prospective, randomised, double-blind trial. Transfusion 40 (2000) 1457-1462
9. Herman J.H. Apheresis platelet transfusions; does ABO matter?. Transfusion 44 (2004) 802-804
10. Carr C., Hutton J.L., Jenkins J.A., Lucas G.F., and Amphlett N.W. Transfusion of ABO-mismatched platelets leads to early platelet refractoriness. Br J Haematol 75 (1990) 408-413
11. Peter-Salonen K., Bucher U., and Nydegger U.E. Comparison of posttransfusion recoveries achieved with either fresh or stored platelet concentrates. Blut 54 (1987) 207-212
12. Norol F., Kuentz M., Cordonnier C., Beaujan C., Haioun F., Vernant C., et al. Br J Haematol 86 (1994) 125-129
13. Dzik S. How I do it: platelet support for refractory patients. Transfusion 47 (2007) 374-378